Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | N/A | UT8802NA | IM / LA |
Employee complained of hives to her mid-belly area and itching to her entire body, especially her legs. Employee noticed onset of symptoms about 30 minutes after receiving Fluzone during annual employee health screening. She also complained of an intense headache, 8/10 pain scale, and dizziness, accompanied by nausea. Denied shortness of breath, no evidence of airway compromise. Vitals were stable throughout monitoring. Onsite physician ordered diphenhydramine 50mg/mL, which was administered IM to right deltoid. Treatment was tolerated well. After continuous monitoring order was discontinued, employee was deemed stable for discharge home with her partner. ED precautions were given along with Rx for diphenhydramine, by mouth, and an EpiPen and instructions provided for medication frequency with f/u to ED for any further symptoms.
Denied having any new foods or new medication.